Helmholtz Diabetes Center Institute of Diabetes Research
The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.
The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.
NOTICE ON OUR OWN BEHALF
Cyberattack - recovery of IT systems ongoing
On March 15, 2023, a cyberattack from an external source was detected at Helmholtz Munich. Immediately extensive defensive measures were taken. As a result, some employees have still very limited access to their email and telephone. Maximum efforts are ongoing to restore the IT- and communication systems. We ask for your understanding and patience if we are unable to respond as quickly as usual or if processes are delayed. Thank you very much.
Highlight publications
See all2022 Journal of Clinical Investigation 2022 Oct 17;132(20):e162123
Elevations in blood glucose before and after the appearance of islet autoantibodies in children.
2020 Journal of the American Medical Association JAMA. 2020;323(4):339-351
Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany.
2019 Diabetes Diabetes 2019;68(4):847–857
2013 Journal of the American Medical Association JAMA. 2013;309(23):2473-2479
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children.